HPLC column NUCLEODUR ® C 18 Gravity, 5 µm, 100 mm, 3 mm
Order number: 35E9.1
Part number: AC100008106
£ 628.88*
*Prices plus VAT plus shipping costs£ 754.66*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Intended for structured formulation workflows, the Hplc Column Nucleodur ® C 18 Gravity, 5 μm, 100 mm, 3 mm offers an ideal solution for reversed phase (RP) separations. Featuring a high density C 18 phase based on high purity NUCLEODUR ® silica gel, this column effectively suppresses unwanted polar interactions, making it suitable for the separation of basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, it is a valuable asset for RP applications, especially in method development. The column comes packaged with one analytical HPLC column, an instruction leaflet, and a certificate of analysis.
- Category: Separation columns for HPLC
- Phase: C 18 Gravity
- Pore size: 110 Å
- Separation principle: Reversed phase (RP)
- Particle size: 5 µm
- Endcapped: yes
- Pore volume: 0.9 ml/g
- USP listing: L1
- Application Database (Macherey-Nagel): HPLC
- Column volume: 0.7 ml
- L x Ø internal (column): 100 x 3 mm
- Surface chemistry: Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification
- Eluent in column: Acetonitrile - Water
- pH stability: 1,0-11,0
- Pressure stability: 600 bar
- Particle type: Fully porous particles (FPP)
- Specific surface according to BET: 340 m²/g
- Column shape: Analytical separation column
- Column type: HPLC column
- Similar phases: NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Temperature stability: 60 ° C
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.7 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 100 x 3 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
| Application Database (Macherey-Nagel) | : | HPLC |
